title: Expression levels and genetic polymorphisms of interleukin-2 and interleukin-10 as biomarkers of Graves' disease.
abstract: The aim of the present study was to determine whether the expression levels of interleukin (IL)-2 and IL-10 may be used as biological markers in Graves' disease (GD) patients. A total of 256 individuals, including 118 GD patients and 138 healthy individuals, were enrolled into the study. Blood samples were collected from each patient and healthy individual, which were then subjected to enzyme-linked immunosorbent assay (ELISA). Total RNA and total proteins were determined using reverse transcription-quantitative polymerase chain reaction (RT-qPCR) and western blot analysis, respectively. In addition, restriction fragment length polymorphism (RFLP) analysis was performed to detect the presence of genetic polymorphisms. The ELISA results indicated that the IL-2 and IL-10 serum levels in the GD patients were increased by ~5.2 and ~7-fold when compared with the levels in the healthy controls. The results of RT-qPCR indicated that the mRNA expression levels of IL-2 and IL-10 were upregulated in the GD patients when compared with the healthy controls. Furthermore, the western blot analysis results revealed that the protein expression levels of IL-2 and IL-10 were significantly increased in the GD patients. RFLP analysis indicated that the increased number of GG single nucleotide polymorphisms (SNPs) in the GD group were detected in the -330 locus of the IL-2 promoter and the -1082 locus of the IL-10 promoter. In addition, the results indicated that the relatively high rates of homozygous GG SNPs (IL-2 -330T/G and IL-10 -1082A/G polymorphisms) on the alleles may be associated with the incidence of GD. The serum, mRNA and protein expression levels of IL-2 and IL-10 were significantly increased in GD patients when compared with the levels in the healthy controls. In conclusion, the expression levels and genetic polymorphisms of IL-2 and IL-10 may be potential biomarkers for the incidence of Graves' disease in the population studied.
authors: Department of Endocrinology, Linyi People's Hospital, Linyi, Shandong 276003, P.R. China.
authors: Cuige
authors: C
authors: Liang
authors: Department of Endocrinology, Linyi People's Hospital, Linyi, Shandong 276003, P.R. China.
authors: Wenhua
authors: W
authors: DU
authors: Department of Endocrinology, Linyi People's Hospital, Linyi, Shandong 276003, P.R. China.
authors: Qingyu
authors: Q
authors: Dong
authors: Department of Endocrinology, Linyi People's Hospital, Linyi, Shandong 276003, P.R. China.
authors: Xiaomeng
authors: X
authors: Liu
authors: Department of Endocrinology, Linyi People's Hospital, Linyi, Shandong 276003, P.R. China.
authors: Wenxia
authors: W
authors: Li
authors: Department of Endocrinology, Linyi People's Hospital, Linyi, Shandong 276003, P.R. China.
authors: Yueli
authors: Y
authors: Wang
authors: Department of Endocrinology, Linyi People's Hospital, Linyi, Shandong 276003, P.R. China.
authors: Guanqi
authors: G
authors: Gao
keywords: Graves’ disease; biomarker; genetic polymorphism; interleukin-10; interleukin-2